(Q77407252)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Switching androgen receptor antagonists to agonists by modifying C-ring substituents on piperidino[3,2-g]quinolinone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

L Zhi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C M Tegley

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

K B Marschke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T K Jones

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

1009-1012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advanced prostatic carcinoma: final report of a double-blind, randomized, multicenter trial. Casodex Combination Study Group

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

Discovery of nonsteroidal androgens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

Synthesis and biological activity of a novel series of nonsteroidal, peripherally selective androgen receptor antagonists derived from 1,2-dihydropyridono[5,6-g]quinolines

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

Novel steroidal pure antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

Discovery of a potent, orally active, nonsteroidal androgen receptor agonist: 4-ethyl-1,2,3,4-tetrahydro-6- (trifluoromethyl)-8-pyridono[5,6-g]- quinoline (LG121071).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900119-5

7 January 2021

10.1016/S0960-894X(99)00119-5

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10230629%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference